Snowball logo
logo
PRLD

Prelude Therapeutics Incorporated

PRLD NASDAQ
$4.08-$0.32  (7.27%)

Frequently asked questions

What sector does Prelude Therapeutics Incorporated (PRLD) operate in?

Prelude Therapeutics Incorporated belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Prelude Therapeutics Incorporated (PRLD) current stock price?

As of the latest data, Prelude Therapeutics Incorporated stock price is $4.08, with a previous close of $4.40. Prelude Therapeutics Incorporated lost -$0.32 in the last trading session, representing a -7.27% loss.

What is Prelude Therapeutics Incorporated (PRLD) current market capitalization?

Prelude Therapeutics Incorporated market cap is approximately 178.56 million.

What is Prelude Therapeutics Incorporated (PRLD) Earnings Per Share (EPS)?

The trailing EPS is -$1.29, and the forward EPS is -$0.44.

What is Prelude Therapeutics Incorporated (PRLD) EBITDA?

Prelude Therapeutics Incorporated EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -16.93 million.

Does Prelude Therapeutics Incorporated (PRLD) pay dividends?

No. Prelude Therapeutics Incorporated does not pay a dividend.

What is Prelude Therapeutics Incorporated (PRLD) beta (volatility) score?

Prelude Therapeutics Incorporated has a beta of 0.874, meaning its volatility is roughly in line with the market.